These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23812078)

  • 21.
    Cho HD; Kim JH; Park JK; Hong SM; Kim DH; Seo KI
    Pharm Biol; 2019 Dec; 57(1):684-693. PubMed ID: 31608754
    [No Abstract]   [Full Text] [Related]  

  • 22. Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells.
    Muñoz-Moreno L; Bajo AM; Prieto JC; Carmena MJ
    Mol Cell Endocrinol; 2017 May; 446():59-69. PubMed ID: 28193499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells.
    Kong D; Banerjee S; Huang W; Li Y; Wang Z; Kim HR; Sarkar FH
    Cancer Res; 2008 Mar; 68(6):1927-34. PubMed ID: 18339874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo.
    Zhou ZY; Zhao WR; Xiao Y; Zhou XM; Huang C; Shi WT; Zhang J; Ye Q; Chen XL; Tang JY
    Acta Pharmacol Sin; 2020 Feb; 41(2):260-269. PubMed ID: 31515528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
    Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
    Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
    Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
    Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.
    Saraswati S; Kumar S; Alhaider AA
    Mol Cancer; 2013 Nov; 12():147. PubMed ID: 24261856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target.
    Gu M; Roy S; Raina K; Agarwal C; Agarwal R
    Cancer Res; 2009 Dec; 69(24):9465-72. PubMed ID: 19920184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.
    Baiz D; Hassan S; Choi YA; Flores A; Karpova Y; Yancey D; Pullikuth A; Sui G; Sadelain M; Debinski W; Kulik G
    Neoplasia; 2013 Oct; 15(10):1172-83. PubMed ID: 24204196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
    Desai B; Rogers MJ; Chellaiah MA
    Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimetastatic effect of halichondramide, a trisoxazole macrolide from the marine sponge Chondrosia corticata, on human prostate cancer cells via modulation of epithelial-to-mesenchymal transition.
    Shin Y; Kim GD; Jeon JE; Shin J; Lee SK
    Mar Drugs; 2013 Jul; 11(7):2472-85. PubMed ID: 23860239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway.
    Xing X; Zhang L; Wen X; Wang X; Cheng X; Du H; Hu Y; Li L; Dong B; Li Z; Ji J
    Anticancer Drugs; 2014 Nov; 25(10):1129-40. PubMed ID: 25035961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor, on DNA-dependent protein kinase.
    Kong D; Yaguchi S; Yamori T
    Biol Pharm Bull; 2009 Feb; 32(2):297-300. PubMed ID: 19182393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.
    Pang X; Yi T; Yi Z; Cho SG; Qu W; Pinkaew D; Fujise K; Liu M
    Cancer Res; 2009 Jan; 69(2):518-25. PubMed ID: 19147565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SYP-5, a novel HIF-1 inhibitor, suppresses tumor cells invasion and angiogenesis.
    Wang LH; Jiang XR; Yang JY; Bao XF; Chen JL; Liu X; Chen GL; Wu CF
    Eur J Pharmacol; 2016 Nov; 791():560-568. PubMed ID: 27664769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways.
    Lü L; Tang D; Wang L; Huang LQ; Jiang GS; Xiao XY; Zeng FQ
    Acta Pharmacol Sin; 2012 Apr; 33(4):531-41. PubMed ID: 22426696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phyllanthus spp. Exerts Anti-Angiogenic and Anti-Metastatic Effects Through Inhibition on Matrix Metalloproteinase Enzymes.
    Tang YQ; Jaganath IB; Manikam R; Sekaran SD
    Nutr Cancer; 2015; 67(5):783-95. PubMed ID: 25996262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual effects of the PI3K inhibitor ZSTK474 on multidrug efflux pumps in resistant cancer cells.
    Muthiah D; Callaghan R
    Eur J Pharmacol; 2017 Nov; 815():127-137. PubMed ID: 28912036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).
    Lin L; Gaut D; Hu K; Yan H; Yin D; Koeffler HP
    Int J Oncol; 2014 Feb; 44(2):557-62. PubMed ID: 24297065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474.
    Isoyama S; Kajiwara G; Tamaki N; Okamura M; Yoshimi H; Nakamura N; Kawamura K; Nishimura Y; Namatame N; Yamori T; Dan S
    Cancer Sci; 2015 Feb; 106(2):171-8. PubMed ID: 25483727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.